Cohort study links genetic risk to problematic cannabis use; initiation age…
Polygenic prediction of cannabis-related outcomes: Evidence from the Avon Longitudinal Study of Parents and Children longitudinal cohort and the European gene-environment interaction case-control study.
AI Summary
This observational study tested whether genetic predispositions—estimated with polygenic risk scores (PRSs)—for cannabis use disorder, depression, insomnia, and chronic pain were associated with cannabis initiation and later problematic use. Researchers analyzed participants in the UK ALSPAC birth cohort and sought conceptual replication in the European EU-GEI case-control study. Cannabis-related outcomes included self-reported use and scores on a questionnaire measuring problematic use; this was not a trial and cannot show that genetic risk causes cannabis use patterns.
In ALSPAC, higher PRSs for cannabis use disorder, depression, and chronic pain were associated with higher problematic-use scores at some measured ages. In EU-GEI, cannabis use disorder and chronic-pain PRSs were associated with weekly-to-daily use; the analysis also found evidence that cannabis use disorder genetic liability and early initiation interacted on an additive scale. The authors report that age at initiation explained more variation in problematic use than any single PRS. These are associations, not evidence of clinical importance or causation. This abstract-based summary cannot establish why the associations occur, and results may not generalize beyond the studied cohorts.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Addiction research papers you might find interesting.
Survey analyses find abstainers can inflate apparent links between substance…
Umbrella review maps widespread comorbidities across substance use disorders
Consultation linked to mixed adherence outcomes in a retrospective study
Explore More Research
Stay informed about the latest cannabis science.